Results 181 to 190 of about 3,984,066 (343)
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner+6 more
wiley +1 more source
Teaching Population Health as a Basic Science at Harvard Medical School
Jonathan A. Finkelstein+5 more
openalex +1 more source
Relationship between emotional intelligence and general health in students of North Khorasan University of Medical Sciences in 2013 [PDF]
M MaddiNeshat+3 more
openalex +1 more source
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva+5 more
wiley +1 more source
Clinical and Translational Research Capacity Building Needs in Minority Medical and Health Science Hispanic Institutions [PDF]
Estela S. Estapé‐Garrastazu+5 more
openalex +1 more source
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon+13 more
wiley +1 more source
Challenges in student assessment in medical and health sciences education in Northern Iraq. [PDF]
Aziz S+6 more
europepmc +1 more source
Medical Malpractice and State Medical Centers: Clarke v. Oregon Health Sciences University
Arthur B. LaFrance
openalex +2 more sources
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source